Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

WESIERSKA-GADEK Jozefa SCHLOFFER Daniela KOTALA Vladimír HORKÝ Marcel

Year of publication 2002
Type Article in Periodical
Magazine / Source International Journal of Cancer
MU Faculty or unit

Faculty of Medicine

Citation
Field Genetics and molecular biology
Keywords apoptosis; nucleolar segregation; E6; cisplatin; PARP-1
Description We previously reported that therapy of human cervical carcinoma HeLa cells with CP induced segregation of nucleoli and changes of nuclei characteristic of apoptosis. We raised the question of whether p53 can be reactivated by chemotherapy in HeLa cells despite the presence of HPV-encoded E6 activity. Since the reduced stability of wild-type p53 protein in HeLa cells is a consequence of its enhanced ubiquitination by virally encoded E6 protein, resulting in its accelerated degradation, we checked the cellular level of E6 during CP therapy. Six hours after application of CP, E6 protein expression was markedly reduced. This coincided with the increase of cellular p53 and preceded the nucleolar accumulation of p53 protein, indicating that repression of virally coded E6 protein by CP contributes to the restoration of p53 expression.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info